Journal of Stem Cells and Clinical Practice

Dr. Kiminobu Sugaya is Professor at Burnett School of Biomedical Sciences in the College of Medicine at University of Central Florida, US. He held several positions during his career. He completed his Ph.D., in the Department of Pharmacology, Faculty of Pharmaceutical Sciences at Tokyo University of Science, Japan and post doctorate studies in Pharmacology at Mayo Clinic Jacksonville and Southern Illinois University, US. He is a member of many professional societies. He has many patents and has numerous publications. 

Research: Dr. Kiminobu Sugaya’s research interest includes Neuropharmacology, Molecular biology, Stem cell biology, Aging and neurodegenerative diseases.

Dr. Xiaoming Yang is working as a professor in the Department of Radiology at University of Washington School of Medicine, US. He completed his PhD of medicine at Kuopio University. He held several positions during his career. He is a member of many professional societies and he is also serving as reviewer and editorial board member for peer reviewed journals. He received many awards. He has numerous publications.

Research: Dr. Xiaoming Yang’s research interests focuses on applying the advances of modern imaging modalities to regenerative medicine, primarily developing new imaging techniques to monitor and guide stem cell-based therapies of life-threatening diseases, such as atherosclerotic cardiovascular disease and cancers.

Dr. Li-Ru Zhao is presently working as Associate Professor in the Department of Neurosurgery at SUNY Upstate Medical University, US.  She completed her Ph.D.  in Wallenberg Neuroscience Center at Lund University, Sweden and Post Doctorate studies at University of Minnesota Medical School, USA.  she received several honors and awards. She has authored numerous articles, Books, book chapters and abstracts. 

Research: Dr. Li-Ru Zhao’s primary research interest includes brain plasticity, stem cell biology, stem cell transplantation, stem cell response to brain injury, stem cell stimulating factors in brain repair, enriched environment in brain repair, live brain imaging, and live cell imaging. Her research also includes search for the therapeutic strategies in brain repair after stroke, CADASIL, Alzheimer’s disease, and traumatic brain injury; understanding the pathogenesis of CADASIL and Alzheimer’s disease.

Dr. Craig S. Atwood is presently working as an Associate Professor in the School of Medicine and Public Health at the University of Wisconsin-Madison, USA. He received his Ph.D. in Biochemistry from the University of Western Australia. He has published over 200 research articles and has received a number of research and teaching awards. He is a member of many professional societies and serves as a reviewer and editorial board member for numerous peer reviewed journals.

Research: Dr. Craig S. Atwood’s research interest includes Hormonal Regulation of Alzheimer's Disease, Embryogenesis, and Aging and Reproduction, Autocrine/Paracrine Mechanisms of LH and Neurosteroid Production in the Brain, Amyloid Biology and Hypoxia, and the Metallobiochemistry of the Brain.

Dr. Baljean Dhillon is currently working as professor of clinical ophthalmology at University of Edinburgh, UK. He completed his BMBS studies at University of Nottingham and FRCS from Royal College of Surgeons of Edinburgh, UK. He has numerous publications in peer reviewed journals. 

Research: Dr. Baljean Dhillon’s research interests include regenerative ophthalmology, imaging and the eye in systemic disease. 

Dr. Ren-Ke Li is a Professor of Medicine in the Department of Surgery, Division of Cardiac Surgery at the University of Toronto.  He is also a Senior Scientist at the Toronto General Research Institute, University Health Network working in the field of stem cell transplantation and tissue engineering. He completed his M.D. at Harbin Medical University in China and his Ph.D. in Clinical Biochemistry at the University of Toronto. He became an Assistant Professor at the University of Toronto in 1993 and was promoted to Full Professor in 2002. Dr. Ren-Ke Li is the recipient of the Canada Research Chair in Cardiac Regeneration (Tier 1) of the Canadian Institutes of Health Research and was a Career Investigator of the Heart and Stroke Foundation of Canada.  He has published 203 peer-reviewed papers in very good Journals and He has been invited to contribute several commentaries and viewpoint articles and is an international opinion leader in his field.  

Research: Dr. Ren-Ke Li’s research focuses on translational research to apply new insights discovered through basic science research to clinical applications for heart regeneration and repair after myocardial infarction. His research areas includes: Cell transplantation into damaged myocardial tissue to regenerate myocardium and restore heart function and Tissue engineering to create a muscle graft using stem cells in combination with biomaterials for repair of cardiac defects. He has used stem cells; gene therapy and tissue engineering technique to regenerate and rejuvenate heart for restore heart function. 

Dr. Xiaoyan Jiang is a Distinguished Scientist in the Terry Fox Laboratory of the BC Cancer Research Centre, a Professor in the Department of Medical Genetics and an Associate Member in the Department of Medicine at the University of British Columbia, Vancouver, Canada. She is also an Adjunct Professor at the Shanghai Institute of Medical Genetics of the Shanghai Jiao Tong University. She has published more than 100 peer-reviewed publications, review articles and book chapters. She is serving as Editorial Board member and as reviewer for many peer reviewed journals.

Research: Dr. Xiaoyan Jiang’s research interests are focused on basic and translational research of molecular properties of leukemic stem cells that contribute to the development of leukemia and drug resistance and she has pioneered efforts to develop new therapeutic approaches to directly target these critical cells.

Dr. Kuldip S. Sidhu is working as Associate Professor at Faculty of Medicine, University of New South Wales, Australia. He completed his PhD in Zoology at Punjab Agricultural University, India and postdoctoral training at Washington University, St Louis MO USA (1979-80) in assisted reproductive technology. He received many awards recently Pioneer in Medicine – SBMT USA 2014 and UNSW Innovation Award – Finalist 2012. He authored numerous books, book chapters, abstracts and research articles. 

Research: Dr. Kuldip S. Sidhu’s current focus is on patient-derived induced pluripotent stem cells and disease modelling

Dr. Eva Mischak-Weissinger is a scientific group leader (head of Laboratory of Transplantation Biology, Hannover Medical School (MHH), Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation. She received “Rudolf-Schön Award” for publication in Blood and Cooperation Award of Lower-Saxony, 1st prize. She is a member of many Scientific Societies. 

Research: Dr. Eva Mischak-Weissinger’s research interests focuses on Complications after allogeneic HSCT (GvHD, CMV-reactivation), proteomics in clinical diagnosis, gene therapy, Gene therapy of Graft versus Host disease, Stem Cell Transplantation: experimental and clinical application and Antigen-specific T-cells: therapeutic and research.

Dr. Bodo-Eckehard Strauer was working as Professor of Internal Medicine-Cardiology in the Department of Cardiology at University of Duesseldorf, Germany. He is also working as Guest Professor in the Department of Cardiac Surgery at University of Rostock, Germany. He has many publications in peer reviewed journals. 

Research: Dr. Bodo-Eckehard Strauer ‘s research interest includes Myocardial contractility, energetics and coronary flow reserve, Hypertension and the Heart and Stem cell research in Cardiology.

Dr. Nils Ole Schmidt is a senior attending neurosurgeon at the Department of Neurosurgery at the University Medical Center Hamburg-Eppendorf in Germany with a clinical focus on neuro-oncological and cerebrovascular surgery. He is head of a research group within the Hans-Dietrich Herrmann Laboratory for Brain Tumor Biology. He graduated from Medical School at the University of Hamburg with several clinical internships in the UK, USA, Switzerland and South Africa. He did his postdoctoral training in the Neurosurgical Oncology Laboratory at the Department of Neurosurgery, Brigham & Women‘s Hospital/Children’s Hospital, Harvard Medical School in Boston, USA and completed his neurosurgical specialization in Hamburg.

Research: Dr. Nils Ole Schmidt‘s research aims for the development of targeted brain tumor therapies with a major focus on stem cell technology, drug delivery, gene therapy, tissue engineering, angiogenesis and MR imaging.

Dr. Marc Poirot is first class research director at the Institut National de la Santé et de la Recherche Médicale (INSERM). He heads the team ‘Sterol metabolism and therapeutic innovations in oncology’ University of Toulouse, France. He received a PhD in Chemical Biology from the University of Toulouse. He did a post-doc at Sanofi in 1991 before becoming tenured at INSERM. He was visiting scientist from 1993 to 1996 in the laboratory of Dr Stoney S. Simons Jr (NIDDK/NIH, Bethesda, USA).  He is co-author of 65 publications and 15 patents.

Research: Dr. Marc Poirot’s research area is focused on the elucidation the mechanisms of action of the anti-tumor drug tamoxifen, which led to the definition of the importance of the microsomal anti-estrogen binding site (AEBS) and of oxysterol metabolism in its pharmacology. His main research interests are the study of deregulations in sterol metabolic pathways in cancers and other degenerative diseases, the identification and the characterization of new sterol metabolites involved in these physiopathologic deregulations. 

Dr. Gianluca Vadala is currently employed at the Campus Bio-Medico University (UCBM) Hospital of Rome in the division of Orthopaedic Surgery. He obtained the PhD in Tissue Regeneration in 2012. In 2013 he received the prestigious AOSpine Young Research Award for his enthusiastic research in spine surgery and regenerative medicine. He published over 32 papers in peer-reviewed journals and obtained several research grant from the Italian Government, Foundations and Scientific Societies.

Research: Dr. Gianluca Vadala’s clinical activity is mainly focused on Regenerative medicine in the orthopedic, Spine Surgery and Trauma fields.

Dr. Zhiyuan Li is working as Principal Investigator in Laboratory of Ion Channels Research at Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, china. He completed his Ph.D. in Pharmacology Department at Central South University, China and in Nutrition Department at Tokushima University, Japan. He was a Post-doctoral Fellow at Pharmacology Department at Vanderbilt University, US. He also worked as Professor, Sheng-Hua Scholar, Director of Anatomy and Neurobiology, Xiang-Ya School of Medicine, Central South University. He received several awards and grants. He authored many articles, books, abstracts and book chapters.  

Research: Dr. Zhiyuan Li’s research is focused on cell membrane ion channels with electrophysiological method patch clamp technique. Regarding the stem cells differentiation, to increase its efficiency and examined the effects of Kv1.3 channel. Kv1.3 specific blocker Psora-4, a small molecule, could improve the efficiency of NSC neuronal differentiation. It also increased the percentage of mature-like neurons. Ion channels crucial roles in pathological processing. The efficient generation of human iPSCs from SMA, Parkinson’s, LNS and Nav mutant epilepsy patients, and then systemically recorded ion channels properties on these differentiated functional neurons. The results demonstrate that iPSCs-derived neurons exhibited a hyperexcitable state. More importantly, patient iPSCs-derived neurons can recapitulate the neuronal pathophysiology and respond to drug treatment, indicating that these neurons can be potentially used for screening appropriate drugs for personalized therapies.

Dr. Jinlian Hua is a professor in the Shaanxi Centre of Stem Cells Engineering & Technology, Key Lab for Animal Biotechnology of Agriculture Ministry at Northwest A&F University, china. He completed his Ph.D and Postdoctoral studies at Northwest Agriculture & Forestry University. He has numerous publications.  

Research: Dr. Jinlian Hua’s research interests include Stem cells, germ cells, Stem cells Biology: Embryonic stem cells, Germ cells, Cardiomyocytes, Signal Transduction and Apoptosis Pathway in Germ Cells, Cancer Therapy, Experimental Therapeutics and Molecular Targets and Genetics and Development Biology.

Dr. Ki Baik Hahm is currently professor of medicine at CHA University School of Medicine and director in CHA Cancer Prevention Research Center and director in Research division of CHA Univ Bundang Medical Center. He graduated from Yonsei University at 1983 and spent three years post-doc in NCI, MD from 1997. After serving assistant professor of Medicine at Yonsei University from 1990 to 1994, he moved to Ajou University School of medicine, where he was appointed as professor of medicine from 1994 to 2006. In 2012 He finally settled in CHA University with prestigious appointment of research driven hospital project as leader, which will be funded from government from 2013 up to 10 years. He had published more than 170 SCI publications and He is taking several researches granted from government. He is currently appointed as president of the Korea Society of Cancer Prevention and Society of Free radical Research.

Research: Dr. Ki Baik Hahm is now performing some translational researches in stem cell applications as well as elimination of cancer stem cells with pharmacological intervention. He serves as editor to Journal of Gastroenterology and Hepatology and Journal of Digestive Disease and editor-in-chief of Clinical Endoscopy journal. Recently he added his filed of research in stem cell application as well as translational research to solve unmet medical needs in gastroenterology.

Dr. Dong-ik Kim is currently working as a Professor in the School of Medicine at Sungkyunkwan University and he is the Chief of Vascular Surgery Division at Samsung Medical Center. He received PhD from Hanyang University. He is a member of many professional societies and Editorial Board member of peer reviewed journals. He has numerous publications in national and international journals.

Research: Dr. Dong-ik Kim’s research interests include Therapeutic angiogenesis using stem cell, Tissue engineering of vascular prosthetic graft, Pathogenesis of intimal hyperplasia, Pathogenesis of thrombosis, Pathogenesis of Buerger's disease and Pathogenesis of atherosclerosis.

Dr. Jae Hwa Kim is working as Professor and vice president in the Department of Orthopedics, CHA Bundang Medical Center at CHA University, Korea. He worked for the orthopaedic department in Cleveland Clinic, US. He is the deputy editor in the Korean Arthroscopy Society and reviewer of the Journal of the Korean Shoulder and Elbow Society. Also he is the member of the Korean Orthopaedic Association, the Korean Knee Society, and the Korean Society of Sports Medicine.

Research: Dr. Jae Hwa Kim’s research interest focuses on Stem Cells and Cell therapy, the massive rotator cuff retear and retear on shoulder arthroscopy, total and reverse total shoulder replacement arthroplaty, and meniscal allograft transplantation.

Dr. Bonghee Lee is currently the professor and director of the Center for Genomics and Proteomics and joint Center for Regenerative Medicine with Sigma-Aldrich at Gachon University. He received his DVM and PhD from Seoul National University. He enrolled for two years as postdoc and visiting professor at University of Pennsylvania, USA. In addition to his responsibilities at Gachon University, he is the co-chair of HUPO’s Human Stem Cell Proteome Initiative, President of the Korean Human Proteome Organization and a board member of the Korean Society for Stem Cell Research. He is also a member of Science Advisory Board for Regenerative Medicine Division of Sigma-Aldrich.

Research: Dr. Bonghee Lee’s research interests include functional proteomics and systems biology of stem cell biology and clinical application. He uses mass spectrometry for identifying lineage specific biomarkers in hESC, iPSC or adult stem cells and gene editing technologies such as ZFN, CRISPR/Cas9 system to generate safe and efficient gene modified stem cells.    

Dr. Inbo Han is currently working as an Associate professor in the Department of Neurosurgery, Spine center at CHA University.  He received his Ph.D. from Yonsei University, South Korea. He is also working as Deputy Research Director, CHA University, prior to this he was a Research fellowship at Laboratory of Spinal Cord Injury & Stem Cell Biology and Brigham & Women’s Hospital/Harvard Medical School, USA He is a member of many Professional Societies and has several publications. 

Research: Dr. Inbo Han’s research area focuses on Reciprocal effects between scaffold properties and human mesenchymal stem cell biology: Implications for spinal cord repair, Neuroprotection resulting from low-dose carbon monoxide inhalation in rat spinal cord injury, Development of cell therapy product for lumbar intervertebral disc degeneration using hyaluronic acid seeded with adipose derived stem cells.

Dr. Insop Shim is presently working as professor in the Department of Medical Science, College of Korean Medicine at Kyung Hee University, South Korea. He obtained his Ph.D from the University of Illinois. He has authored several articles and book chapters. He is a member of many professional societies.   

Research: Dr. Insop Shim’s research interest includes Neural mechanisms underlying stress response; Behavioral neuroscience; Neural mechanisms of drugs of abuse, motivational behaviors; Neurodegenerative diseases; Parkinson' disease, Alzeheimer, Ischemia Learning and Memory; Functional Neuroanatomy and Development of new drugs or stem cells for neurodegenerative diseases.

Dr. Jonathan Keller obtained his Ph.D. at George Washington University, Washington, D.C., where he characterized and purified interleukin 3. He is currently a Principal Investigator in the Center for Cancer Research, National Cancer Institute-Frederick, Frederick, Md, where he is the Head of the Hematopoiesis and Stem Cell Biology Section in the Mouse Cancer Genetics Program. He is also an Adjunct Professor in the Genetics Department at the George Washington University, Washington, D.C.  He has authored numerous manuscripts, holds three patents, and has received awards for his scientific accomplishments in the area of molecular and cellular regulation of hematopoietic cell growth and differentiation.

Research: Dr. Jonathan Keller has a long standing interest in defining the molecular and cellular regulation of hematopoiesis. He characterized and purified interleukin 3, one of the first growth factors that regulate hematopoietic stem cell (HSC) development. He discovered that the proliferation of HSC is balanced by the action of negative growth regulators including transforming growth factor-β. His laboratory is currently focused on understanding how transcription factors regulate HSC quiescence, survival, self-renewal, and cell fate, and how they are integrated into wider transcription factor regulatory networks that regulate HSC development. Dr. Jonathan Keller's areas of expertise includes: 1) Stem Cell Biology 2) Hematopoiesis 3) Transcription Factors 4) Hematopoietic malignancies 5) Molecular regulation of self renewal and cell fate 6) Bone marrow transplantation.  

Dr. Arvind Chhabra is presently working as an Assistant Professor in the Stem Cell Institute at University of Connecticut Health Center, US. He was a Post-Doctoral Research Fellow in the Department of Medicine at University of Connecticut Health Center. He received many awards and honors. He is serving as editorial board member and as reviewer for many peer reviewed journals and has several publications.

Research: Dr. Arvind Chhabra’s primary research interest includes developing an effective immune based cancer therapy and also includes human pluripotent stem cells for developing patient specific cancer immunotherapy approaches through TCR engineering approach.

Dr. Massimo Dominici is currently working as  assistant professor of Medical Oncology and head of the Laboratory of Cellular Therapies at University/Hospital of Modena. He was a  Postdoctoral research associate at St Jude Children's Hospital, USA and also worked as associate professor of Medical Oncology (Nat. Board on Scientific Habilitation). He received many research grants and awards. He authored books, book chapters and about 80 articles, and has Six deposited patents. He is serving as Scientific advisor for the Italian Minister of Health on stem cells (2012). He is the current President of the International Society for Cellular Therapy (ISCT). He has been member of ISCT, ASH, ESCGT, IFATS and board member of JAICE.

Research: Dr. Massimo Dominici’s research interest includes stem cell biology and its translational applications in oncology-hematology and regenerative medicine, focusing on hematopoietic and mesenchymal stromal/stem cells (MSC). The actual projects are aimed to clarify the interactions between MSC and marrow cells to improve bone and marrow regeneration, To develop cancer gene therapy approaches based on immune cells and MSC and To develop tools to increase MSC performance and safety for clinical uses.

Dr. Abdolreza Esmaeilzadeh is presently working as working as Assistant Professor in Clinical Immunology and Head of Immunology department, Faculty of Medicine, Zanjan University of Medical Sciences, Iran. He completed his PhD degree in Medical Immunology at School of Medicine, Tarbiat Modares University. He is also working as Manager of Central Research Laboratory of Advanced Technologies in Medicine and is the Director of Laboratory in Stem Cell research and Therapy Center Zanjan University of Medical Sciences, Iran.

Research: Dr. Abdolreza Esmaeilzadeh’s research interests include Cell and Gene therapy, Immunology of Stem cell, Molecular and Cellular Mechanisms and Immunological Function for Gene Therapy of Cancer Stem cell, Regenerative Medicine and Transplantation.